An interventional study of Intervention group in Stroke and Physical Inactivity, sponsored by Singapore General Hospital. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-04-27.
Sponsored by Singapore General Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 104 studies in Stroke with a site in Singapore — 16 open to participants now, 21 under way, 1 of them phase 3. Stroke · Singapore.
Among the 104 studies in Stroke with a site in Singapore, this one is the 32nd largest by planned enrollment of the 86 interventional ones that give a count, is one of 12 that started in 2024, is one of 58 with no phase, reaches primary completion later than 9 of the 20 other live ones, and was the 85th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →16 of the 104 studies in Stroke with a site in Singapore are open now. Recruiting first, the newest first:
The Hong Kong Polytechnic University · Sites in Singapore, Hong Kong
Ages 21–79 · Healthy volunteers
Tan Tock Seng Hospital · Sites in Singapore
Ages 21–80
National University of Singapore · Sites in Singapore
Ages 21–65
Mah Shi Min · Sites in Singapore
Ages 21–99
Tan Tock Seng Hospital · Sites in Singapore
Ages 50+
A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 21 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
104 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 15 · Phase 4 7
First in 1998; this study’s year is marked. 12 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 51 across the 86 interventional studies, 300 across the 17 observational. Of the 79 that completed or were terminated, 16 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 104 have an industry lead sponsor. The 10 most frequent:
Singapore General Hospital is the lead sponsor of 270 studies on the registry; 57 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Singapore General Hospital has 7 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
6 of the studies in Stroke with a site in Singapore that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06999876National University Health System, SingaporeThe Effect of Combined Transcranial Pulse Current Stimulation (tPCS) and Transcutaneous Electrical Nerve Stimulation (TENS) on Lower Limb Motor Function in Subacute to Chronic Stroke Patients With Hemiplegia (COMPENSATOR-Stroke) | 2026-11-30 |
| NCT06704997Tan Tock Seng HospitalMachine Learning to Predict Factors Affecting Rehabilitation Length of Stay and Healthcare Costs for Neurological Rehabilitation | 2026-12-31 |
| NCT06409351Singapore General HospitalMulti-modal Training Program to Promote Physical Activity After Stroke | 2026-12-31 |
| NCT06073106Tan Tock Seng HospitalTargeting Osteosarcopaenia and Multimorbidity for Frailty Prevention | 2027-01 |
| NCT07122752Tan Tock Seng HospitalFeasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy | 2027-08-29 |
Add all 6 to your calendar (.ics) → With an account.
Among the 104 studies in Stroke with a site in Singapore, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to learn if a behavioral change intervention can improve physical activity in stroke survivors living in the community.
The main question it aims to answer is, if a behaviour change intervention and personalised physical activity prescription, are effective in improving the time spent in moderate to vigorous physical activity amongst chronic stroke survivors.
Researchers will compare the intervention group to a control group, to see if physical activity counselling and a personalized physical activity prescription is more effective in improving moderate to vigorous physical activity, than usual care alone. The study period for each participant is 6 months. Assessments are conducted at month 1 (baseline), 3 and 6.
The control group will receive only usual care, which consists of an information sheet on physical activity with the following content: (1) Why be active and (2) How to be active (with URL links to resources and videos). The usual care is delivered at 3-time points during month 1, 3 and 6.
The intervention group will receive usual care and a behavioral change intervention. The behavioral change intervention consists of up to 6 individual physical activity counselling sessions and a personalized physical activity prescription. The 6 sessions will take place only during months 1 to 3 and there will be no intervention during months 4 to 6. Of the 6 sessions, 3 are conducted face-to-face and another 3 sessions will take place using telehealth methods such as phone, text messaging and videoconference. Participants can meet the study physiotherapist at their preferred exercise space during the 3 face-to-face sessions. The physical activity counselling sessions consist of goal setting and action planning, and problem-solving barriers around participation in physical activity. The overall aim is to increase time spent in moderate-vigorous physical activity.
The MOTIVATE study will take place in Singapore with participants recruited through hospital-based stroke clinics, rehabilitation facilities, and stroke support organizations via posters, email, word of mouth, and social media. Potential participants can sign up by self-registering on the study URL link or through referrals from healthcare professionals and study members. Participants will be screened for eligibility via telephone using the inclusion and exclusion criteria and the Get Active Questionnaire. Participants. Those who have not engaged in regular exercise are required to obtain medical clearance. Informed consent will be taken by a study team member.
This trial will use a 1:1 concealed randomisation, to allocate participants with chronic stroke to an intervention group (n= 60) or control group (n = 60). Between-group comparisons will be made at 3 time points: months 1, 3 and 6.
The control group will receive usual care, which consists of 3 face-to-face sessions on general physical activity recommendations, lasting 30 to 60 minutes each during months 1, 3, and 6. Participants will be given an information sheet on the importance and benefits of physical activity after a stroke and general guidelines on how to start to be active. The general guidelines on how to be active include engaging in 150 minutes of moderate-intensity physical activity per week. The information sheet will also include links to publicly accessible online resources.
The intervention group will receive a behavioural change intervention, in addition to usual care. Information sheet about general guidelines on physical activity will be handed to the intervention group, as per control group. Each participant will receive up to 6 sessions of tailored behavioural change intervention during months 1 to 3 and there will be no intervention during months 4 to 6. Of the 6 sessions, 3 are face-to-face and another 3 will take place using telehealth methods such as phone, text messaging and videoconference. The tailoring of the intervention allows participants to decide the location during face-to-face sessions, how many sessions and how the sessions are spaced out during the 3-month intervention period and which sessions are face-to-face or telehealth. The preferred meeting location may include exercise spaces within home, common spaces just outside their homes and under their housing blocks, outdoor fitness zones or parks near home and residential or inclusive public gyms. The behavioural change intervention consists of physical activity counselling and prescription of a personalized physical activity plan. The first session will be conducted in-person, to allow the study physiotherapist to identify the participant's physical function, safety concerns and the impact of medical, social, environmental and resources on mobility. During the initial visit, the venue, frequency and mode of support (face-to-face or virtual) for subsequent sessions will be established. The study physiotherapist will provide physical activity counselling, set goals and discuss action plans to enhance moderate intensity physical activity, problem solve barriers on physical activity and prescribe a personalized physical activity plan. Subsequent sessions can include (1) training on physical activity modification to accommodate the weak arm and / leg at the participant's preferred exercise location, (2) taking videos of the personalized adapted exercises using the participant's phone when meeting face-to-face and (3) in-person or virtual support sessions to review physical activity progress and action plans.
A process and cost-utility evaluation will be embedded into the study design and conducted concurrently.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Study period: 6 months (1st 3 months intervention, last 3 months no intervention) No. of sessions: up to 6 per participant Mode: 3 sessions are conducted face-to-face and 3 sessions via telehealth methods e.g. phone, text message or video conferencing using virtual platforms like zoom. Where: Face-to-face at the participant's preferred exercise space like home, outdoor fitness zone, parks, gyms etc. Duration of sessions: each face-to-face session will take 60-90 mins Details of intervention: Physical activity counselling on adaptation of exercises, goal setting, action planning, problem solving around barriers to physical activity and provision of study resources
Behavioral: Intervention group
Study period: 6 months No. of sessions: 2 sessions (at month 1 and 3) Mode: Face-to-face Where: At the participant's home Duration of session: 20- 30 minutes Details of control: physical activity information without any other support.
Behavioral: Intervention group
Please refer to arm descriptions
Also known as: MOTIVATE
Duration of moderate to vigorous physical activity
Average minutes/day, measured by Fitbit Inspire 3 tracker
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Number of steps per day
Number of steps per day, measured by Fitbit Inspire 3 tracker
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
International Physical Activity Questionnaire Short Form (IPAQ-SF)
Duration (in minutes) and frequency (days) of walking, moderate-intensity, and vigorous-intensity activity, which are used to compute the total score.
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Modified Rankin Scale
0\. No symptoms 1. No significant disability despite symptoms; able to carry out all usual duties and activities 2. Slight disability: unable to carry out all previous activities but able to look after own affairs without assistance 3. Moderate disability: requiring some help, but able to walk without assistance 4. Moderately severe disability: unable to walk without assistance, and unable to attend to own bodily needs without assistance 5. Severe disability: bedridden, incontinent, and requiring constant nursing care and attention Outcome data: One score from a 6-point scale of 0-5.
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Functional Ambulation Category
0\) Patient cannot walk, or needs help from 2 or more persons 1. Patients needs firm continuous support from 1 person who helps carrying weight and with balance 2. Patient needs continuous or intermittent support of one person to help with balance and coordination 3. Patient requires verbal supervision or stand-by help from one person without physical contact 4. Patient can walk independently on level ground, but requires help on stairs, slopes or uneven surfaces 5. Patient can walk independently anywhere Outcome data: One score from a 6-point scale of 0-5
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Comfortable gait speed
Comfortable walking speed equals to predetermined distance divided by the average time taken from 2 trials to walk that distance comfortably or naturally (e.g., 5m/\_\_sec).
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Fast gait speed
Fast walking speed equals to predetermined distance divided by the average time taken from 2 trials to walk that distance as fast as possibly safe (e.g., 5m/\_\_sec).
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Life-space Assessment Measure
For the five "Life-Space Levels," each "Yes" is given a point value, starting with 1 (life-space level 1) and increasing by 1 point for each life-space level (2 for "Yes" in life-space level 2, 3 for "Yes" in life-space level 3, etc.). For frequency of each life-space level \[less than 1 time per week (score = 1), 1-3 times per week (score = 2), 4-6 times per week (score = 3), or daily (score = 4)\]. For independence level, requiring assistance or use of any equipment \[personal assistance (score = 1), equipment only (score = 1.5), or neither equipment nor personal assistance (score = 2)\]. Outcome data: The total score ranges from 0 ("totally bed-bound") to 120 ("traveling out of town every day without assistance").
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Fall Efficacy Scale International (FES-I)
The Short FES-I consists of seven items Each item is scored on a 4-point scale: 1. Not concerned at all 2. Somewhat concerned 3. Fairly concerned 4. Very concerned Outcome data: Total score ranging from 7 (no concern about falling) to 28 (severe concern about falling).
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Self-Efficacy for Exercise Scale (SEES)
Consists of 9 questions on the individual's confidence in their ability to engage in exercise. Each item is rated on a 11-point scale. Score of 0 indicates "not confident", and score of 10 indicates "very confident". Outcome data: Total score ranges from 0 ("not confident" in own ability to engage in exercise) to 90 ("very confident" in own ability to engage in exercise)
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Fatigue Severity Scale - 7 item (FSS-7)
The FSS-7 consists of seven items, and the responses are scored on a seven-point scale, where 1 indicates "strongly disagree" and 7 indicates "strongly agree." Outcome data: Total score ranges from 7 to 49, with higher scores indicating more severe fatigue and greater impact on activities.
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Fatigue screening tool (SF-CAT)
Yes/no screening questions to 16 questions that cover fatigue, mood, sleep quality, new / uncontrolled conditions, physical / nutrition status, role of medication consumption of alcohol, new / undiagnosed cognitive impairment, speech and language disorder.
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Depression and Anxiety (PHQ-4)
The responses are scored on a four-point scale, where 0 indicates "not at all" and 3 indicates "nearly every day." Outcome data: Total score ranges from 0 to 12, with higher scores indicating greater severity of depression and anxiety symptoms.
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Global Sleep Assessment Questionnaire (GSAQ)
Consists of 11 questions, rated on a 4-point scale ("never", "sometimes", "usually", "always"). Outcome data: More "always" responses indicate better sleep quality.
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
EQ-5D
Outcome data: index values are used in the estimation of quality-adjusted life year (QALY) gains in economic analysis.
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Global Rating of Change on Physical Activity and Fatigue
Score rated on a 15-point scale, ranging from -7 (a very great deal worse) to +7 (a very great deal better). A score of 0 indicates unchanged. Outcome data: One score from the 15-point scale.
Time frame: Month 3 and 6 follow-up.
Adapted Client Service Receipt Inventory (CSRI)
Cost estimate of resource utilization to generate an average cost per participant
Time frame: Initial assessment (month 1), month 3 and 6 follow-up.
Plan to share: Yes — The study protocol with the statistical analysis plan will be published in a peer-reviewed journal.
Supporting information: Study protocol, Statistical analysis plan
Time frame: To be published ahead of the completion of the trial
Access criteria: The protocol will be available as per the publishing journal's options.
Started Jun 2024 (actual). Primary completion is estimated for Dec 2026, 30 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 30 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.